What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

CTCF Gene: Master Organizer of Genome Architecture and Gene Regulation

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to the CTCF Gene

What is CTCF?

The CTCF gene (official symbol CTCF, located on human chromosome 16q22.1) encodes the CCCTC-binding factor, a highly conserved zinc-finger protein that functions as a master organizer of genome architecture and a central regulator of gene expression. The gene spans approximately 80 kilobases and contains at least 12 exons, with alternative splicing generating multiple isoforms. The predominant isoform is an 82 kDa nuclear protein of 727 amino acids that binds to thousands of genomic sites.

CTCF is remarkable for its functional versatility. It acts simultaneously as a transcription factor, an insulator protein, a chromatin barrier, and a structural component of three-dimensional genome organization. It is expressed in virtually all cell types and is essential for viability—homozygous knockout of Ctcf in mice results in early embryonic lethality before the blastocyst stage. This ubiquity and essentiality distinguish CTCF from most sequence-specific transcription factors, which typically regulate smaller gene sets in specific lineages.

Historical discovery and naming

CTCF was first identified in 1990 by Victor Lobanenkov and colleagues as a factor that binds to three regularly spaced CCCTC motifs within the chicken c-myc gene promoter—hence the name CCCTC-binding factor. The initial characterization revealed that CTCF repressed c-myc transcription, establishing it as a sequence-specific DNA-binding protein with transcriptional regulatory activity.

The conceptual breakthrough came in the late 1990s when several laboratories independently discovered that CTCF was the protein responsible for insulator activity at the chicken β-globin locus and the mouse H19 imprinting control region. These findings transformed CTCF from a modest transcription factor into a central player in epigenetics and genome biology. Subsequent genome-wide mapping studies in the 2000s revealed that CTCF binds to tens of thousands of sites across mammalian genomes, positioning it as a global organizer of chromatin structure.

CTCF Protein Structure and DNA Binding

Zinc finger motifs

The defining feature of CTCF is its central DNA-binding domain, composed of 11 tandem C2H2-type zinc fingers. Each zinc finger consists of approximately 30 amino acids arranged in a ββα fold, with two cysteine and two histidine residues coordinating a single zinc ion. The zinc fingers are arranged in a modular array spanning residues 266–577 of the human protein, and they recognize DNA in a sequence-specific manner.

The 11 zinc fingers do not contribute equally to DNA binding. Structural studies have shown that zinc fingers 3–7 make the primary base-specific contacts with the DNA major groove, while the flanking fingers (1–2 and 8–11) contribute to binding affinity and specificity through minor groove interactions and phosphate backbone contacts. This modular architecture allows CTCF to recognize a long (~20 base pair) consensus sequence with high specificity.

Importantly, the zinc finger array is not rigid. Alternative splicing of CTCF exons encoding zinc fingers 3 and 4 can generate isoforms with altered DNA-binding specificity. Additionally, post-translational modifications within the zinc finger region can modulate binding affinity. This flexibility enables CTCF to recognize a diverse set of related motifs rather than a single invariant sequence.

Consensus binding motif

The canonical CTCF binding motif is a GC-rich sequence approximately 20 base pairs in length. The most commonly cited consensus is:

5′-CCGCGNGGNGGCAG-3′

However, this represents only the core recognition sequence. High-throughput binding assays, such as SELEX (systematic evolution of ligands by exponential enrichment) and ChIP-seq (chromatin immunoprecipitation followed by sequencing), have revealed that CTCF binding sites are highly degenerate. Position weight matrix analyses show that no single position is absolutely conserved, and CTCF can tolerate substantial sequence variation across its binding site.

The human genome contains approximately 50,000–80,000 CTCF binding sites, of which roughly 30,000–40,000 are occupied in any given cell type. These sites are non-randomly distributed: they are enriched at boundaries of topologically associating domains (TADs), at gene promoters, and at intergenic regulatory regions. Approximately 50% of CTCF sites are located within gene bodies or promoters, while the remainder fall in intergenic regions.

The degeneracy of the CTCF motif has important functional consequences. It allows CTCF to bind different subsets of sites in different cell types, depending on chromatin accessibility, DNA methylation status, and the availability of cooperating factors. It also means that predicting functional CTCF binding from sequence alone is unreliable—experimental validation is required.

Post-translational modifications affecting binding

CTCF is subject to multiple post-translational modifications that modulate its DNA-binding activity and function. The best-characterized modifications include:

Poly(ADP-ribosyl)ation: PARP1 (poly[ADP-ribose] polymerase 1) adds ADP-ribose polymers to CTCF at multiple sites, particularly within the zinc finger domain. This modification reduces CTCF's DNA-binding affinity, and its removal by PARG (poly[ADP-ribose] glycohydrolase) restores binding. PARP1 activity is regulated by CTCF itself, creating a feedback loop that may control the dynamics of CTCF occupancy.

Phosphorylation: Casein kinase 2 (CK2) phosphorylates CTCF at serine 604, which is required for CTCF's transcriptional repression activity at some promoters. Phosphorylation at other residues can affect nuclear localization or protein stability.

Acetylation: The acetyltransferase p300 acetylates CTCF, and this modification is associated with active chromatin states at CTCF-bound enhancers.

O-GlcNAcylation: Attachment of O-linked N-acetylglucosamine to serine/threonine residues of CTCF has been reported to inhibit its binding to the H19 imprinting control region, providing a link between metabolic state and CTCF function.

These modifications do not simply turn CTCF binding on or off; they create a sophisticated regulatory layer that tunes CTCF occupancy at specific sites in response to cellular signals.

Mechanisms of CTCF in Gene Regulation

Insulator function

The term "insulator" describes a DNA element that establishes a boundary between regulatory domains. CTCF is the primary sequence-specific insulator protein in vertebrates. When bound between an enhancer and a promoter, CTCF can block their interaction; when bound at the edge of a heterochromatic region, it can prevent the spread of repressive chromatin.

The mechanistic basis of CTCF insulator activity lies in its ability to organize chromatin into loops. By tethering two distant CTCF binding sites together through protein-protein interactions, CTCF creates a physical barrier that separates regulatory elements. This loop-based insulation is fundamentally different from the "roadblock" model, in which a bound protein simply impedes the processive movement of regulatory factors along the DNA.

Enhancer-blocking activity

Enhancer-blocking is the classic assay for insulator function. In this assay, a candidate insulator element is placed between an enhancer and a promoter in a reporter construct. If the element blocks enhancer-promoter communication, reporter gene expression decreases.

CTCF exhibits enhancer-blocking activity at many, but not all, of its binding sites. The ability to block enhancer-promoter communication depends on the context: the identity of the enhancer, the distance between elements, and the presence of cooperating proteins all influence whether CTCF acts as an insulator at a given locus.

The mechanism of enhancer-blocking by CTCF is not fully understood, but several models exist. The loop-domain model proposes that CTCF-mediated looping sequesters the enhancer and promoter into separate chromatin domains. The tracking model suggests that CTCF interferes with the processive movement of RNA polymerase or enhancer-associated factors along the DNA. The competition model posits that CTCF competes with enhancer-binding factors for limiting co-activators.

A well-characterized example of CTCF enhancer-blocking occurs at the H19/IGF2 locus, where CTCF binding to the unmethylated maternal imprinting control region blocks the access of the IGF2 promoter to downstream enhancers. This topic is covered in detail in the section on Gene Silencing, which discusses how insulator elements can function as silencers by preventing enhancer-promoter communication.

Barrier activity against heterochromatin

In addition to blocking enhancer-promoter interactions, CTCF can act as a barrier that prevents the spread of heterochromatin into active gene regions. Heterochromatin is characterized by histone H3 lysine 9 methylation (H3K9me) and the binding of heterochromatin protein 1 (HP1). Once nucleated at a specific site, heterochromatin can spread processively along the chromatin fiber, silencing genes in its path.

CTCF barrier activity involves multiple mechanisms. CTCF recruits the chromatin remodeler CHD8, which displaces nucleosomes and creates a nucleosome-free region that impedes heterochromatin spreading. CTCF also interacts with the histone acetyltransferase p300, maintaining high levels of histone acetylation at barrier regions, which antagonizes the deacetylase activity required for heterochromatin formation. Additionally, CTCF can recruit the cohesin complex, which may stabilize the barrier by organizing chromatin into a loop that physically separates the heterochromatic and euchromatic domains.

The barrier function of CTCF is particularly important at developmentally regulated loci, where it maintains the expression of genes adjacent to large heterochromatic domains. For example, at the mouse HoxD cluster, CTCF binding at the boundary between active and repressive chromatin domains prevents the spread of H3K27me3-marked facultative heterochromatin into the active region.

CTCF in Chromatin Architecture and 3D Genome Organization

TAD boundaries

Topologically associating domains (TADs) are self-interacting chromatin regions of approximately 100 kilobases to 1 megabase that represent the fundamental units of genome organization. Within a TAD, sequences interact with each other more frequently than with sequences outside the TAD. TADs are largely invariant across cell types and are conserved across species, suggesting they represent a basic structural feature of genome organization.

CTCF is the primary determinant of TAD boundaries. High-resolution Hi-C maps show that approximately 80% of TAD boundaries are occupied by CTCF, and the orientation of CTCF binding sites at boundaries is highly stereotyped: the two CTCF sites at a boundary are typically arranged in a convergent orientation (one on the forward strand, one on the reverse strand). This orientation specificity is a key feature of the loop extrusion model described below.

The importance of CTCF for TAD formation has been demonstrated by acute depletion experiments. When CTCF is rapidly degraded using auxin-inducible degron technology, TAD boundaries largely disappear within hours, and chromatin interactions become more uniform across the genome. However, the underlying compartment structure (the segregation of active and inactive chromatin) is largely preserved, indicating that CTCF is specifically required for TAD formation but not for higher-order compartmentalization.

Loop extrusion model

The loop extrusion model provides a mechanistic framework for understanding how CTCF and cohesin generate chromatin loops and TADs. According to this model:

The cohesin complex loads onto chromatin at sites determined by the loading factor NIPBL/MAU2.
Cohesin translocates along the DNA fiber, extruding a loop of chromatin as it moves.
The loop grows until cohesin encounters a CTCF protein bound to DNA in the appropriate orientation.
The interaction between cohesin and CTCF stalls loop extrusion, creating a stable chromatin loop anchored by the two CTCF sites.

The orientation dependence of CTCF sites arises from the directional nature of loop extrusion. Cohesin can encounter CTCF from either direction, but it only stops when it encounters CTCF bound in the "correct" orientation relative to its direction of travel. This explains why convergent CTCF sites are enriched at loop anchors and why loops are preferentially formed between convergent sites.

The loop extrusion model makes several testable predictions that have been experimentally verified. First, deleting a CTCF site at a loop anchor eliminates the loop and causes the TAD boundary to weaken or disappear. Second, inverting a CTCF site at one anchor reverses the direction of the loop, causing it to form with a different partner. Third, cohesin depletion eliminates loops but does not affect CTCF binding, indicating that cohesin is the motor that drives loop formation.

Cohesin-CTCF interplay

The relationship between CTCF and cohesin is central to genome organization. Cohesin is a ring-shaped protein complex composed of four core subunits (SMC1, SMC3, RAD21, and STAG1/STAG2) that was originally identified for its role in sister chromatid cohesion during mitosis. In interphase, cohesin also functions in DNA repair and gene regulation, and its role in loop extrusion requires CTCF.

CTCF and cohesin colocalize at approximately 80% of CTCF binding sites in mammalian cells. The interaction between the two proteins is mediated by the STAG (stromal antigen) subunit of cohesin, which binds directly to CTCF. This interaction is required for cohesin to be positioned at CTCF sites and for loop formation.

The dynamics of CTCF-cohesin interactions are highly regulated. Cohesin is loaded onto chromatin by NIPBL and removed by the cohesin release factors WAPL and PDS5. The residence time of cohesin at CTCF sites is approximately 20–30 minutes, while CTCF itself has a residence time of several minutes. This dynamic behavior allows the genome to continuously sample different loop configurations while maintaining stable TAD boundaries on average.

CTCF and Gene Imprinting

Imprinting control regions

Genomic imprinting is an epigenetic phenomenon in which a subset of genes is expressed exclusively from either the maternal or paternal allele. Imprinted genes are typically organized in clusters, and their allele-specific expression is controlled by cis-acting regulatory elements called imprinting control regions (ICRs). ICRs are differentially methylated between the maternal and paternal alleles, and this differential methylation is established during gametogenesis and maintained throughout development.

CTCF plays a central role in the regulation of imprinted gene clusters by binding to ICRs in a methylation-sensitive manner. The best-characterized example is the IGF2-H19 locus on human chromosome 11p15.5, which is discussed in detail in the article on Imprinting Gene.

Methylation-sensitive binding

The IGF2-H19 ICR contains multiple CTCF binding sites that are sensitive to DNA methylation. On the maternal allele, the ICR is unmethylated, allowing CTCF to bind. CTCF binding creates an insulator that blocks the access of IGF2 promoters to enhancers located downstream of H19. As a result, IGF2 is silenced on the maternal allele, and H19 is expressed.

On the paternal allele, the ICR is methylated at CpG dinucleotides within the CTCF binding sites. Methylation of these sites prevents CTCF binding, so no insulator is formed. The enhancers can then activate IGF2 expression, while H19 remains silenced due to promoter methylation. The result is monoallelic expression: IGF2 is expressed only from the paternal allele, and H19 is expressed only from the maternal allele.

The mechanism by which DNA methylation inhibits CTCF binding is direct: the methyl groups on cytosine residues protrude into the major groove of the DNA double helix, where they sterically clash with amino acid side chains of the zinc fingers. This prevents the formation of specific base contacts required for high-affinity binding. The relationship between DNA methylation and CTCF binding is discussed further in the context of DNA Methylation Decrease Gene Expression and DNA Methylation Increase Gene Expression.

Methylation-sensitive CTCF binding is not limited to imprinted loci. Genome-wide studies have identified hundreds of CTCF binding sites whose occupancy is regulated by DNA methylation in normal development and in disease. This provides a mechanism by which changes in DNA methylation can alter genome architecture and gene expression.

CTCF in Development and Disease

CTCF in embryogenesis

CTCF is essential for embryonic development. Mouse embryos lacking Ctcf die before implantation, indicating a requirement for CTCF in the earliest stages of development. Conditional knockout studies have revealed roles for CTCF in multiple developmental processes:

Gastrulation: Deletion of Ctcf in the epiblast leads to defects in mesoderm formation and embryonic lethality at mid-gestation.
Neural development: Loss of CTCF in neural progenitors causes defects in neuronal differentiation and migration, leading to abnormal brain development.
Hematopoiesis: CTCF is required for the proper differentiation of hematopoietic stem cells into mature blood cell lineages.
Cardiac development: Cardiomyocyte-specific deletion of Ctcf results in dilated cardiomyopathy and heart failure.

The developmental functions of CTCF are mediated through its effects on gene expression and genome architecture. During differentiation, CTCF binding patterns change at thousands of sites, and these changes correlate with alterations in TAD structure and enhancer-promoter interactions. The dynamic regulation of CTCF binding during development is discussed in the article on Gene Expression Change Over Time.

CTCF mutations in cancer

CTCF is frequently mutated or dysregulated in human cancers. The mutation spectrum includes:

Loss-of-function mutations: Nonsense, frameshift, and splice-site mutations that truncate the protein or eliminate the zinc finger domain. These are found in approximately 5–10% of breast, prostate, and endometrial cancers.
Missense mutations: Point mutations within the zinc finger domain that alter DNA-binding specificity. These can change the repertoire of CTCF binding sites and lead to aberrant gene expression.
Copy number alterations: Deletions or amplifications of the CTCF locus.
Epigenetic silencing: Hypermethylation of the CTCF promoter, leading to reduced expression.

The functional consequences of CTCF mutations in cancer are diverse. Loss of CTCF can lead to:

Disruption of TAD boundaries, allowing enhancers to inappropriately activate oncogenes.
Loss of insulation at tumor suppressor loci, leading to their silencing.
Altered DNA methylation patterns, as CTCF binding protects some regions from methylation.
Genomic instability, as CTCF is required for proper DNA replication timing and repair.

The role of CTCF in cancer is complex, as it can act as either a tumor suppressor or an oncogene depending on the context. Its frequent mutation in cancer highlights its importance in maintaining normal genome function.

CTCF in neurological disorders

CTCF haploinsufficiency causes a human neurodevelopmental disorder known as CTCF-related syndrome (also called mental retardation, autosomal dominant 21). Affected individuals have intellectual disability, developmental delay, microcephaly, and characteristic facial features. The disorder is caused by heterozygous loss-of-function mutations in CTCF, indicating that a single functional copy of the gene is insufficient for normal brain development.

CTCF has also been implicated in other neurological conditions:

Autism spectrum disorder: Rare CTCF variants have been identified in individuals with autism.
Schizophrenia: Altered CTCF binding has been observed at schizophrenia risk loci.
Huntington's disease: CTCF binding is altered at the HTT locus in affected neurons.

The mechanisms by which CTCF dysfunction leads to neurological phenotypes are not fully understood, but likely involve altered expression of genes required for neuronal development and function, as well as disrupted genome architecture in neurons.

Methods to Study CTCF

ChIP-seq for binding sites

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the standard method for identifying CTCF binding sites genome-wide. The protocol involves:

Crosslinking: Cells are treated with 1% formaldehyde for 10 minutes at room temperature to covalently crosslink CTCF to DNA.
Cell lysis and sonication: Cells are lysed, and chromatin is sheared by sonication to fragments of 200–600 base pairs.
Immunoprecipitation: An antibody specific to CTCF is used to pull down CTCF-DNA complexes.
DNA purification: Crosslinks are reversed by heating at 65°C for 4–6 hours, and DNA is purified.
Library preparation and sequencing: Purified DNA is used to prepare a sequencing library, which is sequenced to a depth of 20–50 million reads.
Peak calling: Computational tools such as MACS2 identify genomic regions enriched for CTCF binding.

ChIP-seq has been used to generate comprehensive maps of CTCF binding in dozens of cell types. These maps have revealed that CTCF binding is largely cell-type invariant, with the majority of sites shared across cell types, but a minority showing cell-type-specific occupancy.

Hi-C and 3C-based methods

Chromosome conformation capture (3C) and its derivatives are used to study the three-dimensional organization of the genome. The most comprehensive of these methods is Hi-C, which captures all pairwise chromatin interactions genome-wide:

Crosslinking: Cells are treated with formaldehyde to fix chromatin interactions.
Digestion: Chromatin is digested with a restriction enzyme (typically HindIII or MboI).
Fill-in and ligation: DNA ends are filled in with biotin-labeled nucleotides, and blunt-end ligation is performed under dilute conditions to favor intramolecular ligation.
DNA purification and shearing: DNA is purified and sheared to 300–500 base pairs.
Biotin pull-down: Biotin-labeled ligation junctions are captured on streptavidin beads.
Library preparation and sequencing: Paired-end sequencing reads identify the two interacting loci.

Hi-C data are used to construct contact maps, from which TADs and chromatin loops are identified. Computational tools such as HiCCUPS and Peakachu identify CTCF-anchored loops by looking for focal interaction peaks at positions of convergent CTCF binding.

CRISPR knockout and degron systems

Functional studies of CTCF require the ability to perturb its expression or binding. Several approaches are available:

CRISPR-Cas9 knockout: Guide RNAs targeting the CTCF gene are introduced with Cas9 to generate frameshift mutations. Because CTCF is essential for cell viability, complete knockout is only possible in cells that can survive without CTCF or in conditional systems.
Conditional knockout: The Ctcf gene is flanked with loxP sites, and Cre recombinase is used to delete the gene in a tissue-specific or temporally controlled manner.
Auxin-inducible degron (AID): The AID system allows rapid degradation of CTCF protein within minutes of adding auxin (indole-3-acetic acid). This system has been used to study the acute effects of CTCF loss on genome architecture.
dCas9-CTCF fusion: A catalytically dead Cas9 (dCas9) fused to CTCF can be targeted to specific genomic loci to test the functional consequences of CTCF binding at defined positions.

Each approach has advantages and limitations. CRISPR knockout is permanent but slow, allowing compensatory changes to occur. The AID system is fast but requires tagging of the endogenous protein, which may affect its function.

Common Misconceptions and Pitfalls

CTCF is not always an insulator

A common misconception is that CTCF always functions as an insulator. In reality, CTCF has multiple, context-dependent functions. At some loci, CTCF acts as an insulator; at others, it functions as a transcriptional activator or repressor; at still others, it serves purely as a structural protein organizing chromatin loops without directly affecting gene expression.

The outcome of CTCF binding depends on:

The specific binding site and its sequence context.
The presence of cooperating proteins (cohesin, YY1, etc.).
The local chromatin environment.
The orientation of the binding site relative to other regulatory elements.

Therefore, it is incorrect to assume that a CTCF binding site automatically creates an insulator. Functional assays are required to determine the actual role of CTCF at a given locus.

Binding site context matters

Another pitfall is assuming that CTCF binding alone determines function. The same CTCF binding site can have different effects in different cell types or developmental stages, depending on the availability of interacting partners and the state of the local chromatin.

For example, CTCF binding sites at TAD boundaries are often occupied in all cell types, but the strength of the boundary can vary. This variability is determined by the density of CTCF binding, the presence of additional boundary factors such as USF1 or ZNF143, and the local histone modification state.

Additionally, the orientation of CTCF binding sites is critical for loop formation. Convergent sites form loops; divergent sites do not. This orientation dependence is a frequent source of confusion for students learning about CTCF function.

CTCF vs. cohesin functions

CTCF and cohesin are often discussed together, leading to confusion about their distinct roles. While both proteins are required for loop formation and TAD organization, they have different functions:

Feature	CTCF	Cohesin
DNA binding	Sequence-specific (20 bp motif)	Sequence-independent, loaded by NIPBL
Primary function	Insulator, transcription factor, boundary element	Sister chromatid cohesion, loop extrusion, DNA repair
Binding sites	~50,000–80,000 per genome	~10,000–20,000 per genome
Residence time	Minutes	20–30 minutes
Effect of depletion	Loss of TAD boundaries, altered gene expression	Loss of loops, sister chromatid cohesion defects, cell death
Orientation dependence	Yes, for loop formation	No, but CTCF stops extrusion

Cohesin can bind and function at sites without CTCF, and CTCF can bind and function without cohesin. The two proteins cooperate at loop anchors, but they have independent roles elsewhere in the genome.

Summary and Key Takeaways

CTCF is a multifunctional protein that plays essential roles in gene regulation and genome organization. Its 11 zinc fingers recognize a degenerate DNA motif, allowing it to bind thousands of sites across the genome. CTCF functions as an insulator, enhancer-blocker, and chromatin barrier, and it is the primary determinant of TAD boundaries through its interaction with cohesin. Methylation-sensitive CTCF binding underlies genomic imprinting at loci such as IGF2-H19. CTCF is essential for development, and its mutation or dysregulation contributes to cancer and neurodevelopmental disorders.

Frequently Asked Questions

What is the CTCF gene?

The CTCF gene encodes CCCTC-binding factor, a zinc-finger protein that regulates gene expression and organizes three-dimensional genome architecture. It is located on chromosome 16q22.1 in humans and is expressed in virtually all cell types.

What does CTCF stand for?

CTCF stands for CCCTC-binding factor, named for its discovery as a protein that binds to three regularly spaced CCCTC motifs in the chicken c-myc gene promoter.

How does CTCF regulate gene expression?

CTCF regulates gene expression through multiple mechanisms: it acts as an insulator that blocks enhancer-promoter interactions, as a barrier that prevents heterochromatin spreading, and as a transcription factor that directly activates or represses target genes. It also organizes chromatin loops that bring regulatory elements into proximity.

What is the role of CTCF in 3D genome organization?

CTCF is the primary determinant of TAD boundaries. It binds to convergent sites at loop anchors and interacts with cohesin to stabilize chromatin loops formed by loop extrusion. This organization partitions the genome into regulatory domains that constrain enhancer-promoter interactions.

Is CTCF a protein or a gene?

CTCF is both. The CTCF gene encodes the CTCF protein. In common usage, "CTCF" typically refers to the protein, while "CTCF gene" or "CTCF" (italicized) refers to the genetic locus.

What happens when CTCF is mutated?

CTCF mutations cause a range of phenotypes depending on the nature of the mutation. Heterozygous loss-of-function mutations cause CTCF-related syndrome, characterized by intellectual disability and developmental delay. Somatic mutations in cancer can disrupt genome organization and gene regulation, contributing to tumor development.

How is CTCF studied experimentally?

CTCF is studied using ChIP-seq to map binding sites, Hi-C and 3C-based methods to analyze chromatin architecture, CRISPR and degron systems to perturb CTCF function, and reporter assays to test insulator and enhancer-blocking activity. The relationship between CTCF and epigenetic regulation is further explored in the context of Epigenetics vs Gene Environment Interaction.

Key Takeaways

CTCF is an essential, ubiquitously expressed zinc-finger protein that binds thousands of genomic sites through a degenerate 20-base-pair motif.
CTCF functions as an insulator, enhancer-blocker, and chromatin barrier, and its activity is modulated by post-translational modifications and DNA methylation.
CTCF is the primary organizer of TAD boundaries and chromatin loops, working together with cohesin through the loop extrusion mechanism.
Methylation-sensitive CTCF binding at imprinting control regions establishes allele-specific gene expression at imprinted loci such as IGF2-H19.
CTCF is required for embryonic development, and its mutation causes neurodevelopmental disorders and contributes to cancer.
CTCF function is highly context-dependent; binding alone does not predict function, and CTCF does not always act as an insulator.
Modern genomic techniques including ChIP-seq, Hi-C, and CRISPR-based perturbation are essential for studying CTCF's diverse roles.